HPI-1, 5 mg

A potent chemical probe for hypoxia research, this prolyl hydroxylase inhibitor from STEMCELL Technologies stabilizes HIF-1α under normoxic conditions by blocking PHD enzyme activity. The 5 mg format supports cell culture experiments investigating angiogenesis, metabolic adaptation, stem cell pluripotency maintenance, and directed differentiation protocols. Each vial delivers consistent performance in vitro across multiple freeze-thaw cycles when stored at -20°C and protected from light. Reconstitution in DMSO is recommended to prepare concentrated stocks before dilution into working media. Intended for research use only, this tool enables controlled mimicry of low-oxygen signaling without specialized hypoxic chambers.